Related references
Note: Only part of the references are listed.Cancer statistics, 2020
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2020)
Association of Anti-TNF with Decreased Survival in Steroid Refractory Ipilimumab and Anti-PD1-Treated Patients in the Dutch Melanoma Treatment Registry
Rik J. Verheijden et al.
CLINICAL CANCER RESEARCH (2020)
Overt Thyroid Dysfunction and Anti-Thyroid Antibodies Predict Response to Anti-PD-1 Immunotherapy in Cancer Patients
Edwin A. Basak et al.
THYROID (2020)
Granzyme B is correlated with clinical outcome after PD-1 blockade in patients with stage IV non-small-cell lung cancer
Daan P. Hurkmans et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
CD45RA+CCR7- CD8 T cells lacking co-stimulatory receptors demonstrate enhanced frequency in peripheral blood of NSCLC patients responding to nivolumab
Andre Kunert et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Five-Year Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma
J. Larkin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Immune-related adverse events correlate with improved survival in patients undergoing anti-PD1 immunotherapy for metastatic melanoma
Alice Indini et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2019)
Melanoma and autoimmunity: spontaneous regressions as a possible model for new therapeutic approaches
Ion G. Motofei
MELANOMA RESEARCH (2019)
Genetic effects on gene expression across human tissues (vol 550, pg 204, 2017)
NATURE (2018)
Association between single-nucleotide polymorphisms and adverse events in nivolumab-treated non-small cell lung cancer patients
Sander Bins et al.
BRITISH JOURNAL OF CANCER (2018)
PD-L1(+) tumor-associated macrophages and PD-1(+) tumor-infiltrating lymphocytes predict survival in primary testicular lymphoma
Marjukka Pollari et al.
HAEMATOLOGICA (2018)
Meta-analysis of the association of IL2RA polymorphisms rs2104286 and rs12722489 with multiple sclerosis risk
Xiao-Xiong Wang et al.
IMMUNOLOGICAL INVESTIGATIONS (2018)
Patients with melanoma treated with an anti-PD-1 antibody beyond RECIST progression: a US Food and Drug Administration pooled analysis
Julia A. Beaver et al.
LANCET ONCOLOGY (2018)
PD-L1(+) tumor-associated macrophages and PD-1(+) tumor-infiltrating lymphocytes predict survival in primary testicular lymphoma
Marjukka Pollari et al.
HAEMATOLOGICA (2018)
PD-1/PD-L1 and VEGF-A/VEGF-C expression in lymph node microenvironment and association with melanoma metastasis and survival
Cristina Alessi et al.
MELANOMA RESEARCH (2017)
High proportion of PD-1-expressing CD4+ T cells in adipose tissue constitutes an immunomodulatory microenvironment that may support HIV persistence
Abderaouf Damouche et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2017)
Association between interferon-γ+874 T/A polymorphism and susceptibility to autoimmune diseases: a meta-analysis
Y. H. Lee et al.
LUPUS (2016)
Evaluation of Immune-Related Response Criteria and RECIST v1.1 in Patients With Advanced Melanoma Treated With Pembrolizumab
F. Stephen Hodi et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Prognostic impact of programed cell death-1 (PD-1) and PD-ligand 1 (PD-L1) expression in cancer cells and tumor infiltrating lymphocytes in colorectal cancer
Yaqi Li et al.
MOLECULAR CANCER (2016)
Genome-wide association studies of autoimmune vitiligo identify 23 new risk loci and highlight key pathways and regulatory variants
Ying Jin et al.
NATURE GENETICS (2016)
Low programmed cell death-1 (PD-1) expression in peripheral CD4+ T cells in Japanese patients with autoimmune type 1 diabetes
R. Fujisawa et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2015)
Vitiligo-Like Depigmentation in Patients With Stage III-IV Melanoma Receiving Immunotherapy and Its Association With Survival: A Systematic Review and Meta-Analysis
Hansje-Eva Teulings et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Meta-analysis of genetic polymorphisms in programmed cell death 1 Associations with rheumatoid arthritis, ankylosing spondylitis, and type 1 diabetes susceptibility
Y. H. Lee et al.
ZEITSCHRIFT FUR RHEUMATOLOGIE (2015)
Association of ZAP70 and PTPN6, but Not BANK1 or CLEC2D, with Inflammatory Bowel Disease in the Tunisian Population
Dorra Bouzid et al.
GENETIC TESTING AND MOLECULAR BIOMARKERS (2013)
Molecular Pathways: Next-Generation Immunotherapy-Inhibiting Programmed Death-Ligand 1 and Programmed Death-1
Daniel S. Chen et al.
CLINICAL CANCER RESEARCH (2012)
A Comprehensive Analysis of Shared Loci between Systemic Lupus Erythematosus (SLE) and Sixteen Autoimmune Diseases Reveals Limited Genetic Overlap
Paula S. Ramos et al.
PLOS GENETICS (2011)
Interferon-gamma gene polymorphisms associated with susceptibility to systemic lupus erythematosus
Kwangwoo Kim et al.
ANNALS OF THE RHEUMATIC DISEASES (2010)
Association of IL2RA and IL2RB with rheumatoid arthritis: a replication study in a Dutch population
F. A. S. Kurreeman et al.
ANNALS OF THE RHEUMATIC DISEASES (2009)
New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
E. A. Eisenhauer et al.
EUROPEAN JOURNAL OF CANCER (2009)
Polymorphisms of PTPN11 Coding SHP-2 as Biomarkers for Ulcerative Colitis Susceptibility in the Japanese Population
Yukiko Narumi et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2009)
Rheumatoid arthritis susceptibility loci at chromosomes 10p15, 12q13 and 22q13
Anne Barton et al.
NATURE GENETICS (2008)
How regulatory T cells work
Dario A. A. Vignali et al.
NATURE REVIEWS IMMUNOLOGY (2008)
A triple-mutated allele of granzyme B incapable of inducing apoptosis
D McIlroy et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
SNP alleles in human disease and evolution
BS Shastry
JOURNAL OF HUMAN GENETICS (2002)
Share Paper
